Synergistic interaction between anti-IFN alpha/beta antibody and low doses of cyclosporine therapy prolongs heart transplants in rats.
Militerno
G
G
Laboratoire de Recherches Chirurgicales, Hôpital Saint-Roch, Nice, France.
Gugenheim
J
J
Cuomo
O
O
Hofman
P
P
Mouiel
J
J
Tovey
M
M
D000818:Animals; D000906:Antibodies / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use*; D004357:Drug Synergism; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology*; D016027:Heart Transplantation / Q000276:immunology*; D016898:Interferon-alpha / Q000276:immunology*; D016899:Interferon-beta / Q000276:immunology*; D008297:Male; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D013997:Time Factors
D000906:Antibodies; D016898:Interferon-alpha; D016899:Interferon-beta; D016572:Cyclosporine